EVANSVILLE, Ind., Oct. 17, 2017 -- Vectren Corporation (NYSE:VVC) will announce its 2017 third quarter results after the market closes on Thursday, November 2, 2017. Vectren management plans to discuss those results during a conference call at 2:00 p.m. ET on Friday, November 3, 2017. To participate in the call, analysts should dial 1-844-825-9787 ten minutes prior to the start time and refer to the Vectren Corporation 2017 Third Quarter Earnings Call.
All interested investors may listen to a live audio-only webcast accompanied by a slide presentation, which will be available on Vectren’s Investor Relations homepage, investors.vectren.com, by clicking on the “Q3 2017 Earnings Webcast” link near the top of the page. A replay of the webcast will be made available at the same location approximately two hours following the conclusion of the call.
About Vectren
Vectren Corporation (NYSE:VVC) is an energy holding company headquartered in Evansville, Ind. Vectren’s energy delivery subsidiaries provide gas and/or electricity to more than 1 million customers in adjoining service territories that cover nearly two-thirds of Indiana and west central Ohio. Vectren’s nonutility subsidiaries and affiliates currently offer energy-related products and services to customers throughout the U.S. These include infrastructure services and energy services. To learn more about Vectren, visit www.vectren.com.
Investor Contact: Dave Parker, (812) 491-4135, [email protected]
Media Contact: Chase Kelley, (812) 491-4128, [email protected]


Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 



